Johnson & Johnson Ottava

Next-generation surgical robot in development by J&J/Ethicon. 6-arm configuration, general surgery focus.

Yes. Johnson & Johnson Ottava is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

Johnson & Johnson Ottava is made by Johnson & Johnson, based in New Brunswick, New Jersey, USA, founded in 1886.

3 verified deployments of Johnson & Johnson Ottava are on the DEPLOY registry, including at California, United States, New Brunswick.

Johnson & Johnson Ottava is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.

On the DEPLOY registry, comparable surgical robots to Johnson & Johnson Ottava include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.

Johnson & Johnson Ottava and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. Johnson & Johnson Ottava has 3 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Johnson & Johnson Ottava ranks in roughly the top 19% of surgical models tracked by the registry.

Johnson & Johnson Ottava is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

Johnson & Johnson Ottava has 5 active incidents on record in the DEPLOY registry. 5 incidents on record (3 moderate, 2 minor). Most recent: Jul 2026. Retracted incidents are excluded from this count.